Close Menu

Note: This story has been updated with comments from Abbott's earnings call.

NEW YORK — Abbott reported Wednesday that its fourth quarter diagnostics revenues rose 111 percent year over year due to strong sales related to the firm's COVID-19 products.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.